These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 15814471

  • 21. Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.
    Chiseliţă D, Antohi I, Medvichi R, Danielescu C.
    Oftalmologia; 2005; 49(3):39-45. PubMed ID: 16408674
    [Abstract] [Full Text] [Related]

  • 22. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R, Queiroz CF, Santos LC, Avila MP, Magacho L.
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [Abstract] [Full Text] [Related]

  • 23. Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops.
    Nakakura S, Nomura Y, Ataka S, Shiraki K.
    J Glaucoma; 2007 Mar; 16(2):201-4. PubMed ID: 17473730
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
    Plummer CE, MacKay EO, Gelatt KN.
    Vet Ophthalmol; 2006 Mar; 9(4):245-9. PubMed ID: 16771760
    [Abstract] [Full Text] [Related]

  • 25. [Stereospecificity of lowering intraocular pressure using a locally administered carbonic anhydrase inhibitor].
    Diestelhorst M, Bechetoille A, Lippa E, Brunner-Ferber F, Krieglstein GK.
    Fortschr Ophthalmol; 1990 Mar; 87(2):131-3. PubMed ID: 2358266
    [Abstract] [Full Text] [Related]

  • 26. Effects of moderate changes in intraocular pressure on ocular hemodynamics in patients with primary open-angle glaucoma and healthy controls.
    Weigert G, Findl O, Luksch A, Rainer G, Kiss B, Vass C, Schmetterer L.
    Ophthalmology; 2005 Aug; 112(8):1337-42. PubMed ID: 16024084
    [Abstract] [Full Text] [Related]

  • 27. A randomized study of dorzolamide in the prevention of elevated intraocular pressure after anterior segment laser surgery. Dorzolamide Laser Study Group.
    Hartenbaum D, Wilson H, Maloney S, Vacarelli L, Orillac R, Sharpe E.
    J Glaucoma; 1999 Aug; 8(4):273-5. PubMed ID: 10464738
    [Abstract] [Full Text] [Related]

  • 28. [Efficacy of pneumatic traheculoplasty (PNT) in patients with open angle glaucoma and ocular hypertension--a preliminary report].
    Wierzbowska J, Stankiewicz A, Romańska Ł.
    Klin Oczna; 2008 Aug; 110(7-9):287-91. PubMed ID: 19112863
    [Abstract] [Full Text] [Related]

  • 29. A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma.
    Siesky B, Harris A, Cantor LB, Kagemann L, Weitzman Y, McCranor L, Marques C, Werne A, Stefansson E.
    Br J Ophthalmol; 2008 Apr; 92(4):500-4. PubMed ID: 18369067
    [Abstract] [Full Text] [Related]

  • 30. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects.
    Nesher R, Ticho U.
    Isr Med Assoc J; 2003 Apr; 5(4):260-3. PubMed ID: 14509130
    [Abstract] [Full Text] [Related]

  • 31. [Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
    Pfeiffer N, Grehn F, Hennekes R, Garus H.
    Fortschr Ophthalmol; 1990 Apr; 87(2):128-30. PubMed ID: 2192972
    [Abstract] [Full Text] [Related]

  • 32. Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension.
    Gudmundsdóttir E, Stefánsson E, Bjarnadóttir G, Sigurjónsdóttir JF, Gudmundsdóttir G, Masson M, Loftsson T.
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3552-4. PubMed ID: 11006251
    [Abstract] [Full Text] [Related]

  • 33. The effect of timolol-dorzolamide and timolol-pilocarpine combinations on ocular blood flow in patients with glaucoma.
    Uva MG, Longo A, Reibaldi M, Reibaldi A.
    Am J Ophthalmol; 2006 Jun; 141(6):1158-60. PubMed ID: 16765700
    [Abstract] [Full Text] [Related]

  • 34. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF, Krupin T, Tang LQ, Hong PH, Ruderman JM.
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [Abstract] [Full Text] [Related]

  • 35. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M, Grigera DE, Barbosa WL, Jordao M, Susanna R.
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [Abstract] [Full Text] [Related]

  • 36. Concordance of diurnal intraocular pressure between fellow eyes in primary open-angle glaucoma.
    Dinn RB, Zimmerman MB, Shuba LM, Doan AP, Maley MK, Greenlee EC, Alward WL, Kwon YH.
    Ophthalmology; 2007 May; 114(5):915-20. PubMed ID: 17467528
    [Abstract] [Full Text] [Related]

  • 37. Randomised fellow eye comparison of the effectiveness of dorzolamide and apraclonidine on intraocular pressure following phacoemulsification cataract surgery.
    Rainer G, Menapace R, Findl O, Georgopoulos M, Kiss B, Heinze G.
    Eye (Lond); 2000 Oct; 14 Pt 5():757-60. PubMed ID: 11116699
    [Abstract] [Full Text] [Related]

  • 38. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR, Yan DB, Chartrand JP, Piemontesi RL, Simonyi S, Hollander DA.
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment.
    Konstas AG, Kozobolis VP, Tsironi S, Makridaki I, Efremova R, Stewart WC.
    Ophthalmology; 2008 Jan; 115(1):99-103. PubMed ID: 18166407
    [Abstract] [Full Text] [Related]

  • 40. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.
    Seki M, Tanaka T, Matsuda H, Togano T, Hashimoto K, Ueda J, Fukuchi T, Abe H.
    Br J Ophthalmol; 2005 Apr; 89(4):504-7. PubMed ID: 15774933
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.